Well the statements below were put out in a PR back in September 25, 2013 regarding dCellVax:
The PR said they are currenly working on phase A. Based on the timelines mentioned and the date of the PR, you could expect the IND submission to be as early as March and as late as the end of May, early June.
I try not to get too excited without actual news, but it sounds to me like Koos is perfectly timing all of this, assuming he was able to keep everything on schedule.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.